SCHEMBL24901669

SCHEMBL24901669

COC(=O)c1cc(Br)c([N+](=O)[O-])c(OC(F)(F)F)c1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 3/20 0.45
PDK2 Q15119 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALPL P05186 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 1/20 0.38
MAPT P10636 2/20 0.36
ALDH1A1 P00352 2/20 0.36
POLB P06746 2/20 0.36
ABL1 P00519 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
VCAM1 P19320 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3646690 0.79 NOTUM (0.43) NOTUMKDM4ESMN1; SMN2HTTMAPT
SCHEMBL31123060 0.79 NOTUM (0.43) NOTUMKDM4ESMN1; SMN2HTTMAPT
SCHEMBL31309588 0.78 KMT2A (0.42) SMN1; SMN2MAPTALDH1A1POLBABL1
SCHEMBL24901671 0.78 NOTUM (0.49) NOTUMPDK2KDM4EALPLHTT
SCHEMBL23970388 0.75 KDM4E (0.45) NOTUMKDM4ESMN1; SMN2HTTMAPT
SCHEMBL670581 0.75 NOTUM (0.55) NOTUMPDK2KDM4EALPLHTT
SCHEMBL31055865 0.75 SMN1; SMN2 (0.40) NOTUMKDM4ESMN1; SMN2HTTMAPT
SCHEMBL2240748 0.75 NOTUM (0.59) NOTUMPDK2KDM4EALPLSMN1; SMN2
SCHEMBL4314290 0.75 NOTUM (0.63) NOTUMPDK2KDM4EALPLHTT
SCHEMBL31651636 0.74 HPGD (0.41) NOTUMKDM4ESMN1; SMN2HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240382471-A1 GLUCAGON-LIKE PEPTIDE-1 RECEPTOR MODULATORS AND USES THEREOF Hepagene Therapeutics (HK) Limited (CN) 2024-11-21 US disclosed
CN-117715906-A Glucagon-like peptide-1 receptor modulators and uses thereof 和博医药有限公司 2024-03-15 CN disclosed
WO-2023001237-A1 GLUCAGON-LIKE PEPTIDE-1 RECEPTOR MODULATORS AND USES THEREOF Hepagene Therapeutics (HK) Limited (CN) 2023-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240382471-A1 GLUCAGON-LIKE PEPTIDE-1 RECEPTOR MODULATORS AND USES THEREOF GLP1R, GIPR, GCGR NOTUM 2026/4885PDK2 1999/4885KDM4E 3593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.